Compare OPXS & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OPXS | BDSX |
|---|---|---|
| Founded | 1987 | 2005 |
| Country | United States | United States |
| Employees | 72 | N/A |
| Industry | Electronic Components | Precision Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 91.7M | 101.7M |
| IPO Year | 2009 | 2020 |
| Metric | OPXS | BDSX |
|---|---|---|
| Price | $12.77 | $15.40 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $32.50 |
| AVG Volume (30 Days) | 57.6K | ★ 118.5K |
| Earning Date | 01-01-0001 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.55 | N/A |
| EPS | ★ 0.03 | N/A |
| Revenue | $24,530,000.00 | ★ $88,499,000.00 |
| Revenue This Year | N/A | $22.01 |
| Revenue Next Year | N/A | $26.81 |
| P/E Ratio | $419.67 | ★ N/A |
| Revenue Growth | 17.63 | ★ 24.08 |
| 52 Week Low | $5.36 | $0.25 |
| 52 Week High | $17.76 | $14.17 |
| Indicator | OPXS | BDSX |
|---|---|---|
| Relative Strength Index (RSI) | 46.73 | 74.96 |
| Support Level | $12.54 | $6.33 |
| Resistance Level | $14.16 | N/A |
| Average True Range (ATR) | 1.03 | 1.55 |
| MACD | -0.11 | 0.25 |
| Stochastic Oscillator | 54.08 | 73.52 |
Optex Systems Holdings Inc manufactures optical sighting systems and assemblies for the U.S. Department of Defense, foreign military applications, and commercial markets. Its products are installed on a variety of United States military land vehicles, such as the Abrams and Bradley fighting vehicles, light armored and security vehicles, and have been selected for installation on the Stryker family of vehicles. The company's operating segment includes Optex Systems Richardson, Applied Optics Center Dallas, and others. It generates maximum revenue from the Optex Systems Richardson segment. Some of its products include M17 Day/Thermal Periscope; DDAN / M36 Sights; Laser Protected Periscopes; Muzzle Reference Sensor, and others.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.